Evidence map›Paper›PMID 33737874›Full record

ArticleFrontiers in pharmacology2020

Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study.

Kjell-Erik Arnesen, Ann Vinh Phung, Karoline Randsborg, Irene Mork, Marlene Thorvall, Gisle Langslet, Arne Svilaas, Cecilie Wium, Leiv Ose, Kjetil Retterstøl

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kjell-Erik ArnesenLipid Clinic, Oslo University Hospital, Oslo, Norway.
Ann Vinh PhungDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Karoline RandsborgDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Irene MorkDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Marlene ThorvallDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Gisle LangsletLipid Clinic, Oslo University Hospital, Oslo, Norway.
Arne SvilaasLipid Clinic, Oslo University Hospital, Oslo, Norway.
Cecilie WiumLipid Clinic, Oslo University Hospital, Oslo, Norway.
Leiv OseLipid Clinic, Oslo University Hospital, Oslo, Norway.
Kjetil RetterstølLipid Clinic, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ASCVDcolesevelamezetrimibefamilial hypercholesterolemiaPCSK9-inhibitorside effectstatinTTTFH

Identifiers

PMID33737874
PMCPMC7961401
OpenAlexW3134790990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.